EVENT DATE: April 12, 2007
TOPIC: Cancer: Are we close to a cure?

The topic was of great interest to everyone.  There is no better authority in Canada than Dr Eisenhauer to give an assessment on progress in the battle to conquer it.  Since 1982, she has been Director of the Investigational New Drug Program of the Clinical Trials Group at the National Cancer Institute of Canada (NCIC).  Her major responsibilities lie in identifying and bringing new anti-cancer agents into clinical trial.  In 2002 she was appointed to the Board of Directors of the NCIC and in 2006 was elected as its President.